Yeast-Based Aβ1-15 Vaccine Elicits Strong Immunogenicity and Attenuates Neuropathology and Cognitive Deficits in Alzheimer's Disease Transgenic Mice.
Yeast-Based Aβ1-15 Vaccine Elicits Strong Immunogenicity and Attenuates Neuropathology and Cognitive Deficits in Alzheimer's Disease Transgenic Mice.
复制标题
DOI:
10.3390/vaccines8030351
复制
发表时间:
2020-07-01
期刊:
影响因子:
7.8
通讯作者:
Liu RT
中科院分区:
文献类型:
--
作者:
Liu DQ;Lu S;Zhang L;Huang YR;Ji M;Sun XY;Liu XG;Liu RT
Immunotherapy focusing on reducing the amyloid-beta (Aβ) burden is a promising treatment strategy for Alzheimer’s disease (AD). Many clinical studies on AD immunotherapies have failed due to low safety and efficacy, calling for a highly potent AD vaccine which induces sufficient antibody titer while avoiding side effects. Here, we designed a yeast-based vaccine Y-5A15 comprising five copies of Aβ1-15 displayed on the surface of yeast cell wall, and we subcutaneously immunized APP/PS1 mice three times. Our results demonstrated that the Y-5A15 remarkably enhanced the Aβ epitope immunogenicity and elicited high antibody titers against Aβ in AD mice. Importantly, Y-5A15 vaccination successfully reduced Aβ levels, plaque burden and glial activation, rescued synaptic deficits and significantly ameliorated memory and cognitive decline in APP/PS1 transgenic mice, suggesting that the yeast-based Aβ epitope vaccine has a promising potency for the treatment of AD.
登录
查看更多内容
DOI:
10.3233/jad-179941
发表时间:
2018
期刊:
Journal of Alzheimer's disease : JAD
影响因子:
--
作者:
Cline EN;Bicca MA;Viola KL;Klein WL
通讯作者:
Klein WL
影响因子:
25
作者:
Cleary, JP;Walsh, DM;Ashe, KH
通讯作者:
Ashe, KH
影响因子:
3.7
作者:
Mandler M;Santic R;Gruber P;Cinar Y;Pichler D;Funke SA;Willbold D;Schneeberger A;Schmidt W;Mattner F
通讯作者:
Mattner F
影响因子:
168.9
作者:
Holmes, Clive;Boche, Delphine;Nicoll, James A. R.
通讯作者:
Nicoll, James A. R.
DOI:
10.1073/pnas.95.11.6448
发表时间:
1998-05-26
影响因子:
11.1
作者:
Lambert, MP;Barlow, AK;Klein, WL
通讯作者:
Klein, WL